AntriaBio Inc Share Price OTC Bulletin Board
Equities
US0372301095
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
22/05 | Traders Cautious Ahead of Fed Minutes, Nvidia Earnings, Stifling US Equity Futures Pre-Bell | MT |
22/05 | Top Premarket Gainers | MT |
Sales 2024 * | - | Sales 2025 * | 2.35Cr 195.9Cr | Capitalization | 16Cr 1.35TCr |
---|---|---|---|---|---|
Net income 2024 * | -6.3Cr -525.5Cr | Net income 2025 * | -4.9Cr -408.72Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.6Cr 717.34Cr | Net cash position 2025 * | 6.8Cr 567.2Cr | EV / Sales 2025 * | 3.99 x |
P/E ratio 2024 * |
-3.44
x | P/E ratio 2025 * |
-5.14
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.6% |
Latest transcript on AntriaBio Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 26/10/26 | |
Nevan Elam
CEO | Chief Executive Officer | 56 | 26/10/26 |
Daron Evans
DFI | Director of Finance/CFO | 50 | 24/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nevan Elam
CEO | Chief Executive Officer | 56 | 26/10/26 |
Young-Jin Kim
BRD | Director/Board Member | 67 | 10/19/10 |
Gil Labrucherie
BRD | Director/Board Member | 52 | 20/19/20 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr |